Abdalla H, Van Dyke T
Front Dent Med. 2025; 4:1129371.
PMID: 39916899
PMC: 11797759.
DOI: 10.3389/fdmed.2023.1129371.
Zou X, Huang Q, Kang T, Shen S, Cao C, Wu J
Biol Direct. 2025; 20(1):4.
PMID: 39789601
PMC: 11715544.
DOI: 10.1186/s13062-025-00593-3.
Dang W, Li F, Gao R, Zhang C, Cheng H, Wu Z
Int J Mol Sci. 2025; 25(24.
PMID: 39769164
PMC: 11676269.
DOI: 10.3390/ijms252413399.
Pitchai A, Shinde A, Swihart J, Robison K, Shannahan J
Nanomaterials (Basel). 2024; 14(20).
PMID: 39452978
PMC: 11510677.
DOI: 10.3390/nano14201642.
Jeevithan L, Diao X, Hu J, Elango J, Wu W, Mate Sanchez de Val J
Front Cell Infect Microbiol. 2024; 14:1422648.
PMID: 39359937
PMC: 11445226.
DOI: 10.3389/fcimb.2024.1422648.
Inhibition of Soluble Epoxide Hydrolase by Cembranoid Diterpenes from Soft Coral : Enzyme Kinetics, Molecular Docking, and Molecular Dynamics.
Phong N, Thao N, Vinh L, Luyen B, Minh C, Yang S
Mar Drugs. 2024; 22(8).
PMID: 39195489
PMC: 11355918.
DOI: 10.3390/md22080373.
Machine learning based on metabolomics unveils neutrophil extracellular trap-related metabolic signatures in non-small cell lung cancer patients undergoing chemoimmunotherapy.
Li Y, Su J, Tan S, Chen X, Cheng T, Jiang Z
World J Clin Cases. 2024; 12(20):4091-4107.
PMID: 39015934
PMC: 11235537.
DOI: 10.12998/wjcc.v12.i20.4091.
Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors.
Kundu B, Dvoracsko S, Basu A, Pommerolle L, Kim K, Wood C
Molecules. 2024; 29(13).
PMID: 38998987
PMC: 11242993.
DOI: 10.3390/molecules29133036.
The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids.
Jiang S, Han S, Wang D
Front Pharmacol. 2024; 15:1358256.
PMID: 38628644
PMC: 11019020.
DOI: 10.3389/fphar.2024.1358256.
Soluble epoxide hydrolase deficiency attenuates airway inflammation in COPD via IRE1α/JNK/AP-1 signaling pathway.
Yu Y, Yang A, He X, Wu B, Wu Y, Li Y
J Inflamm (Lond). 2023; 20(1):36.
PMID: 37915073
PMC: 10621191.
DOI: 10.1186/s12950-023-00361-y.
Inhibitory Activity of Natural -Khellactone on Soluble Epoxide Hydrolase and Proinflammatory Cytokine Production in Lipopolysaccharides-Stimulated RAW264.7 Cells.
Kim J, Park J, Koo S, Huh Y, Hur M, Park W
Plants (Basel). 2023; 12(20).
PMID: 37896119
PMC: 10610198.
DOI: 10.3390/plants12203656.
Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase attenuated particulate matter 2.5 exposure mediated lung injury.
Zhang J, Zhang W, Morisseau C, Zhang M, Dong H, Zhu Q
J Hazard Mater. 2023; 458:131890.
PMID: 37406527
PMC: 10699546.
DOI: 10.1016/j.jhazmat.2023.131890.
Noncanonical Regulation of cAMP-Dependent Insulin Secretion and Its Implications in Type 2 Diabetes.
Ramanadham S, Turk J, Bhatnagar S
Compr Physiol. 2023; 13(3):5023-5049.
PMID: 37358504
PMC: 10809800.
DOI: 10.1002/cphy.c220031.
Enhancement of the liver's neuroprotective role ameliorates traumatic brain injury pathology.
Dai Y, Dong J, Wu Y, Zhu M, Xiong W, Li H
Proc Natl Acad Sci U S A. 2023; 120(26):e2301360120.
PMID: 37339206
PMC: 10293829.
DOI: 10.1073/pnas.2301360120.
Dihydroxy-Metabolites of Dihomo-γ-linolenic Acid Drive Ferroptosis-Mediated Neurodegeneration.
Sarparast M, Pourmand E, Hinman J, Vonarx D, Reason T, Zhang F
ACS Cent Sci. 2023; 9(5):870-882.
PMID: 37252355
PMC: 10214511.
DOI: 10.1021/acscentsci.3c00052.
Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease.
Muniyandi A, Hartman G, Song Y, Mijit M, Kelley M, Corson T
J Pharmacol Exp Ther. 2023; 386(1):15-25.
PMID: 37142441
PMC: 10289243.
DOI: 10.1124/jpet.122.001563.
Mix-and-Read Nanobody-Based Sandwich Homogeneous Split-Luciferase Assay for the Rapid Detection of Human Soluble Epoxide Hydrolase.
He Q, McCoy M, Yang H, Lin M, Cui X, Zhao S
Anal Chem. 2023; 95(14):6038-6045.
PMID: 36972550
PMC: 10335774.
DOI: 10.1021/acs.analchem.3c00079.
Dihydroxy-Metabolites of Dihomo-gamma-linolenic Acid Drive Ferroptosis-Mediated Neurodegeneration.
Sarparast M, Pourmand E, Hinman J, Vonarx D, Reason T, Zhang F
bioRxiv. 2023; .
PMID: 36711920
PMC: 9881903.
DOI: 10.1101/2023.01.05.522933.
CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury.
Leuillier M, Duflot T, Menoret S, Messaoudi H, Djerada Z, Groussard D
J Adv Res. 2022; 43:163-174.
PMID: 36585106
PMC: 9811321.
DOI: 10.1016/j.jare.2022.03.004.
Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.
Noh M, Jang H, Salem F, Ferrer F, Kim J, Padanilam B
Am J Physiol Renal Physiol. 2022; 324(2):F138-F151.
PMID: 36475868
PMC: 9844979.
DOI: 10.1152/ajprenal.00052.2022.